Nobuhiko Ikari

456 total citations
17 papers, 353 citations indexed

About

Nobuhiko Ikari is a scholar working on Molecular Biology, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nobuhiko Ikari has authored 17 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nobuhiko Ikari's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Enzyme function and inhibition (3 papers) and Synthesis and Catalytic Reactions (2 papers). Nobuhiko Ikari is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Enzyme function and inhibition (3 papers) and Synthesis and Catalytic Reactions (2 papers). Nobuhiko Ikari collaborates with scholars based in Japan and United States. Nobuhiko Ikari's co-authors include Yuji Hitomi, Setsuro Fujii, Yoshiharu Sakai, Satoshi Fujii, Sadaaki Iwanaga, Teruko Sugo, Setsuro Fujii, Hisao Kato, Michio Niinobe and Alan C. Moses and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemistry and FEBS Letters.

In The Last Decade

Nobuhiko Ikari

17 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuhiko Ikari Japan 10 91 85 65 61 49 17 353
Laszlo Leb United States 11 77 0.8× 117 1.4× 65 1.0× 84 1.4× 44 0.9× 14 532
Evelyn Gaynor United States 7 35 0.4× 122 1.4× 91 1.4× 67 1.1× 49 1.0× 12 434
S S Levinson United States 12 25 0.3× 202 2.4× 54 0.8× 75 1.2× 67 1.4× 28 437
Mee Jeong Lee South Korea 14 42 0.5× 82 1.0× 84 1.3× 65 1.1× 36 0.7× 28 349
L Jakab Hungary 10 15 0.2× 112 1.3× 125 1.9× 22 0.4× 89 1.8× 46 464
Yew Koon Lim Singapore 8 59 0.6× 205 2.4× 22 0.3× 31 0.5× 108 2.2× 12 500
Sumith R. Panicker United States 12 39 0.4× 109 1.3× 128 2.0× 87 1.4× 30 0.6× 23 395
Tsutomu Urayama Japan 10 33 0.4× 65 0.8× 28 0.4× 206 3.4× 13 0.3× 22 496
Xinmiao Wang China 10 40 0.4× 204 2.4× 108 1.7× 107 1.8× 45 0.9× 25 496

Countries citing papers authored by Nobuhiko Ikari

Since Specialization
Citations

This map shows the geographic impact of Nobuhiko Ikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuhiko Ikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuhiko Ikari more than expected).

Fields of papers citing papers by Nobuhiko Ikari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuhiko Ikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuhiko Ikari. The network helps show where Nobuhiko Ikari may publish in the future.

Co-authorship network of co-authors of Nobuhiko Ikari

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuhiko Ikari. A scholar is included among the top collaborators of Nobuhiko Ikari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuhiko Ikari. Nobuhiko Ikari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Yamasaki, Hironori, Shoichi Akazawa, S. Okuno, et al.. (1992). Regional differences in insulin receptor function in Werner's syndrome. Diabetes Research and Clinical Practice. 15(2). 105–111. 5 indexed citations
2.
Yokota, Atsushi, Yoshihiko Yamaguchi, Yasuo Ueda, et al.. (1990). Comparison of islet cell antibodies, islet cell surface antibodies and anti-bovine serum albumin antibodies in type 1 diabetes. Diabetes Research and Clinical Practice. 9(3). 211–217. 10 indexed citations
3.
Saku, Takashi, Y. Shibata, Jung‐Chien Cheng, et al.. (1990). Autoantibodies to keratin in Sjögren's syndrome. Journal of Oral Pathology and Medicine. 19(1). 45–48. 5 indexed citations
4.
Yokota, Atsushi, Yuji Yamaguchi, Tomoko Nakanishi, et al.. (1990). Comparison of islet cell antibodies, islet cell surface antibodies and anti-bovine serum albumin antibodies in type 1 diabetes. Journal of Autoimmunity. 3(1). 102–102. 2 indexed citations
5.
Ikari, Nobuhiko, Hiroko Yoshino, Alan C. Moses, & Jeffrey S. Flier. (1988). Evidence that Receptor Aggregation may Play a Role in Transmembrane Signaling through the Insulin-Like Growth Factor-I Receptor. Molecular Endocrinology. 2(9). 831–837. 20 indexed citations
6.
Ikari, Nobuhiko, Hisashi Ohta, Masami Niwa, et al.. (1987). Inhibitory effects of condensed tannins on angiotensin converting enzyme.. The Japanese Journal of Pharmacology. 43(2). 242–246. 30 indexed citations
7.
Ikari, Nobuhiko, Hisashi Ohta, Masami Niwa, et al.. (1987). Inhibitory Effects of Condensed Tannins on Angiotensin Converting Enzyme. The Japanese Journal of Pharmacology. 43(2). 242–246. 7 indexed citations
8.
Yamashita, Shunichi, Naokata Yokoyama, Shigeki Morita, et al.. (1986). Stimulation of thyroid adenylate cyclase activity by sera from patients with non-thyroidal illness. European Journal of Endocrinology. 113(3). 340–345. 4 indexed citations
9.
Kurata, A, T. Fukuda, Nobuhiko Ikari, et al.. (1985). Production of a monoclonal antibody to a membrane antigen of human T-cell leukaemia virus (HTLV1/ATLV)-infected cell lines from a systemic lupus erythematosus (SLE) patient: serological analyses for HTLV1 infections in SLE patients.. PubMed. 62(1). 65–74. 11 indexed citations
10.
Hitomi, Yuji, Nobuhiko Ikari, & Setsuro Fujii. (1985). Inhibitory Effect of a New Synthetic Protease Inhibitor (FUT-175) on the Coagulation System. Pathophysiology of Haemostasis and Thrombosis. 15(3). 164–168. 99 indexed citations
11.
Kurata, A, Kazuhiro Ohta, Takaaki Fukuda, et al.. (1984). Monoclonal Antihuman Thyroglobulin Antibodies. The Journal of Clinical Endocrinology & Metabolism. 59(4). 573–579. 13 indexed citations
12.
Ikari, Nobuhiko, Yoshiharu Sakai, Yuji Hitomi, & Satoshi Fujii. (1983). New synthetic inhibitor to the alternative complement pathway.. PubMed. 49(4). 685–91. 60 indexed citations
13.
Ikari, Nobuhiko, Yuji Hitomi, Michio Niinobe, & Setsuro Fujii. (1983). Studies on esterolytic activity of alternative complement component factor B. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 742(2). 318–323. 10 indexed citations
14.
Ikari, Nobuhiko, Michio Niinobe, & Setsuro Fujii. (1981). Proteolysis of factor B by plasma kallikrein and plasmin. FEBS Letters. 131(1). 143–146. 6 indexed citations
16.
Sugo, Teruko, Nobuhiko Ikari, Hisao Kato, Sadaaki Iwanaga, & Setsuro Fujii. (1980). Functional sites of bovine high molecular weight kininogen as a cofactor in kaolin-mediated activation of factor XII (Hageman factor). Biochemistry. 19(14). 3215–3220. 43 indexed citations
17.
Kato, H., Teruko Sugo, Nobuhiko Ikari, et al.. (1979). Role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine Factor XII.. PubMed. 120B. 19–37. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026